A Rare Case of New-Onset Ulcerative Colitis following Initiation of Secukinumab

Secukinumab is an IgG monoclonal antibody widely used for treatment of ankylosing spondylitis, psoriasis, and psoriatic arthritis. Recently, there has been increasing controversy regarding potential adverse effects of the drug especially in those with underlying inflammatory bowel disease. We presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Achufusi, Ted George, Harnee, Prateek S., Rawlins, Sekou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701396/
https://www.ncbi.nlm.nih.gov/pubmed/31467555
http://dx.doi.org/10.1155/2019/2975631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701396/
https://www.ncbi.nlm.nih.gov/pubmed/31467555
http://dx.doi.org/10.1155/2019/2975631

Ejemplares similares